Influenza Vaccine: Federal Investments in Alternative Technologies and Challenges to Development and Licensure

Download or read book Influenza Vaccine: Federal Investments in Alternative Technologies and Challenges to Development and Licensure written by Marcia Crosse and published by DIANE Publishing. This book was released on 2011-10-07 with total page 58 pages. Available in PDF, EPUB and Kindle. Book excerpt: Production delays for the 2009 H1N1 pandemic vaccine using the current egg-based production technology heightened interest in alternative technologies that could expand the supply or accelerate the availability of influenza vaccine. Within the federal government, the Dept. of Health and Human Services (HHS) and the Dept. of Defense (DOD) support the development of technologies that can be used in producing technologies that can be used in producing influenza vaccines. HHS’s Food and Drug Admin. (FDA) reviews licensing applications for new vaccine, and the Dept. of State is the U.S. diplomatic liaison to the international entity that declares worldwide pandemics. This report examines (1) federal funding from FY 2005 through March 2011 for alternative technologies and the status of manufacturers’ efforts, (2) challenges to development and licensure identified by stakeholders, and (3) how HHS is addressing those challenges. Tables and figures. This is a print on demand report.